Vectus Biosystems Limited logo

VBSVectus Biosystems Limited

VBS Stock Price, Valuation & Chart | Vectus Biosystems Limited

Compare

VBS Historical price chart

VBS Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization11.75M
PE Ratio-7.19
EPS-0.03
Trading Volume43
Today's High/Low0.19/0.19
Dividend Yield0.00
52 Week High/Low0.46/0.05
Shares Outstanding61.87M
VBS Financial Statement
VBS Analyst ratings
VBS Analysis & performance metrics

VBS Company profile

Vectus Biosystems Limited engages in the medical research and development activities in Australia. The company develops treatment for fibrosis and high blood pressure, which…

VBS Management team

Management
Robert John Waring BEc, CA, FAICD, FCIS, FFin
Company Secretary
Graham Jon MacDonald AM, BS, BSc (Med), FANZCC, FRACP, FRCP, M.D.
Consultant
Ivan Rajkovic Ph.D.CTO
Interim Chief Technology Officer
Total 3 executives

VBS Frequently asked questions

What is Vectus Biosystems Limited (VBS) Stock Price?

Current stock price of Vectus Biosystems Limited (VBS) stock is $0.190. The stock price is +2.70% higher in the session. The intraday range can be seen from this page. Volume of Vectus Biosystems Limited (VBS) stock is 43.

Last updated at 02 Sept 2026, 05:19 am.

Why is the Vectus Biosystems Limited (VBS) stock price going up or down today?

The stock price of Vectus Biosystems Limited (VBS) can change with earnings, company news, and overall market sentiment. Vectus Biosystems Limited operates in the Healthcare / Unknown market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Vectus Biosystems Limited stock expensive at its current price?

Whether Vectus Biosystems Limited looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for VBS on this page is -7.19. EPS on this page is -0.03. Compare those figures with peers and growth expectations before deciding if the current Vectus Biosystems Limited price is justified.

How has the stock price of Vectus Biosystems Limited (VBS) performed historically?

Historical performance for Vectus Biosystems Limited (VBS) is shown on the price chart on this page. Review multi-period moves alongside volume to see how VBS reacted to past earnings and market events.

Should I buy Vectus Biosystems Limited (VBS) stock, at this price?

Buying Vectus Biosystems Limited (VBS) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.